Literature DB >> 29643064

Racial Heterogeneity in Treatment Effects in Peripheral Artery Disease: Insights From the CLEVER Trial (Claudication: Exercise Versus Endoluminal Revascularization).

Yashashwi Pokharel1, Philip G Jones2, Garth Graham2, Tracie Collins2, Judith G Regensteiner2, Timothy P Murphy2, David Cohen2, John A Spertus2, Kim Smolderen2.   

Abstract

Entities:  

Keywords:  continental population groups; exercise; goals; humans; walking

Mesh：

Year:  2018        PMID： 29643064      PMCID： PMC5901766          DOI： 10.1161/CIRCOUTCOMES.117.004157

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN： 1941-7713


× No keyword cloud information.
  7 in total

1.  Ethnic-specific prevalence of peripheral arterial disease in the United States.

Authors:  Matthew A Allison; Elena Ho; Julie O Denenberg; Robert D Langer; Anne B Newman; Richard R Fabsitz; Michael H Criqui
Journal:  Am J Prev Med       Date:  2007-04       Impact factor: 5.043

2.  A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity.

Authors:  J Ware; M Kosinski; S D Keller
Journal:  Med Care       Date:  1996-03       Impact factor: 2.983

3.  2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Thom W Rooke; Alan T Hirsch; Sanjay Misra; Anton N Sidawy; Joshua A Beckman; Laura K Findeiss; Jafar Golzarian; Heather L Gornik; Jonathan L Halperin; Michael R Jaff; Gregory L Moneta; Jeffrey W Olin; James C Stanley; Christopher J White; John V White; R Eugene Zierler
Journal:  J Am Coll Cardiol       Date:  2011-10-06       Impact factor: 24.094

4.  Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study.

Authors:  Timothy P Murphy; Donald E Cutlip; Judith G Regensteiner; Emile R Mohler; David J Cohen; Matthew R Reynolds; Joseph M Massaro; Beth A Lewis; Joselyn Cerezo; Niki C Oldenburg; Claudia C Thum; Suzanne Goldberg; Michael R Jaff; Michael W Steffes; Anthony J Comerota; Jonathan Ehrman; Diane Treat-Jacobson; M Eileen Walsh; Tracie Collins; Dalynn T Badenhop; Ulf Bronas; Alan T Hirsch
Journal:  Circulation       Date:  2011-11-16       Impact factor: 29.690

5.  Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study.

Authors:  Timothy P Murphy; Donald E Cutlip; Judith G Regensteiner; Emile R Mohler; David J Cohen; Matthew R Reynolds; Joseph M Massaro; Beth A Lewis; Joselyn Cerezo; Niki C Oldenburg; Claudia C Thum; Michael R Jaff; Anthony J Comerota; Michael W Steffes; Ingrid H Abrahamsen; Suzanne Goldberg; Alan T Hirsch
Journal:  J Am Coll Cardiol       Date:  2015-03-17       Impact factor: 24.094

6.  The peripheral artery questionnaire: a new disease-specific health status measure for patients with peripheral arterial disease.

Authors:  John Spertus; Philip Jones; Sherri Poler; Krishna Rocha-Singh
Journal:  Am Heart J       Date:  2004-02       Impact factor: 4.749

Review 7.  Patient-reported outcome measures in patients with peripheral arterial disease: a systematic review of psychometric properties.

Authors:  Edith Poku; Rosie Duncan; Anju Keetharuth; Munira Essat; Patrick Phillips; Helen Buckley Woods; Simon Palfreyman; Georgina Jones; Eva Kaltenthaler; Jonathan Michaels
Journal:  Health Qual Life Outcomes       Date:  2016-11-24       Impact factor: 3.186
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.